Searchable abstracts of presentations at key conferences in endocrinology

ea0003p303 | Thyroid | BES2002

The use of lithium as an adjunct to radioiodine therapy for thyrotoxicosis

Murphy E , Bassett J , Frank J , Meeran K

Following the establishment of a telephone clinic follow-up for patients receiving radioiodine for recurrent thyrotoxicosis, we wished to further improve our results in achieving hypo(eu)thyroidism while minimising the risk of transient hyperthyroidism and thyroid storm post-therapy. Although not widely used, lithium has been shown to increase the effectiveness of radioiodine therapy, leading to prompter control of hyperthyroidism. Since August 2001, patients undergoing radioi...

ea0019p209 | Growth and development | SFEBES2009

The effect of age on insulin-like growth factor-I and pro-collagen type III N-terminal peptide in elite adolescent athletes and its influence on the detection of growth hormone abuse

Guha N , Erotokritou-Mulligan I , Brigg J , Burford C , Drake T , Strobridge G , Bassett E , Cowan D , Bartlett C , Sonksen P , Holt R

Introduction: Using discriminant analysis, a method based on two growth hormone (GH) dependent markers, insulin-like growth factor-I (IGF-I) and pro-collagen type III N-terminal peptide (P-III-P) has been devised to detect exogenously administered GH. It is believed that GH is a popular substance of abuse amongst adolescent athletes. As previous studies on the detection of GH abuse involved predominantly adult athletes, it is necessary to validate the method in adolescent athl...